EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A glycoprotein D-targeted lipid nanoparticle-encapsulated mRNA vaccine elicits strong protective immunity against pseudorabies virus

Yue Sun, Shi-Jia Xu, Yongfei Zhou, Yanhe Zhang, Hongliang Zhang iD, Ting Le, Yuan-Zhe Bai, Cui-Hong Rao, Shanshan Huo, Tianceng Zhou, Tong-Qing An, Xin Yin und 3 weitere

Journal of Virology · 25.11.2025 · 99 (11)

DOI: 10.1128/jvi.01472-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 25.11.2025. Verfasst von Yue Sun und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Har…. Hauptthemen laut MEDLINE: Pseudorabies, Herpesvirus 1, Suid, Nanoparticles, Viral Envelope Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China National Key Research and Development Program during the 14-th Five-year Plan Period.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pseudorabies virus (PRV), a highly contagious pathogen with zoonotic potential, continues to threaten swine production and public health due to the emergence of virulent variants and insufficient protection conferred by conventional live attenuated vaccines. Although commercial vaccines are safe for pigs, their residual pathogenicity in other susceptible species underscores the demand for universally safe alternatives. Here, we engineered a lipid nanoparticle-encapsulated mRNA vaccine (mRNA-LNPs) expressing PRV glycoprotein D (gD) and evaluated its efficacy in murine and porcine models. In mice, vaccination with gD mRNA-LNPs elicited potent neutralizing antibodies and provided complete protection against lethal PRV challenge. In piglets, immunization induced rapid humoral immune responses, significantly reduced viral loads in tissues and viral shedding post-challenge, and alleviated histopathological damage. Mechanistically, except for its ability to elicit neutralizing antibodies, the vaccine also stimulated antigen-specific CD3 + CD4 + T-cell and CD3 + CD8 + T-cell proliferation and enhanced IFN-γ production, demonstrating robust activation of both humoral and cellular immunity. These findings establish gD mRNA-LNPs as a safe, effective, and broadly applicable vaccine candidate for PRV control across susceptible species, with advantages in scalability and biosafety over traditional platforms. IMPORTANCE The emergence of virulent pseudorabies virus (PRV) variants and the insufficient cross-species protection conferred by conventional live attenuated vaccines pose significant challenges to global swine production and zoonotic biosecurity. Here, we developed a lipid nanoparticle-encapsulated mRNA vaccine (gD mRNA-LNPs) targeting PRV glycoprotein D (gD), a critical mediator of viral entry. This vaccine elicits robust neutralizing antibodies and potent T-cell responses, providing complete protection against lethal PRV challenge in both murine and porcine models. Unlike traditional vaccines, gD mRNA-LNPs eliminates residual pathogenicity risks and demonstrates broad efficacy against diverse PRV strains, including emerging variants. Its scalable production platform and ability to differentiate vaccinated from infected animals via serological diagnostics align with One Health strategies for PRV eradication. This study establishes mRNA-LNPs technology as a versatile, safe, and effective solution for combating PRV, with implications for improving livestock health and reducing zoonotic spillover threats.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PseudorabiesHerpesvirus 1, SuidNanoparticlesViral Envelope ProteinsPseudorabies VaccinesAnimalsSwineMiceAntibodies, NeutralizingAntibodies, ViralmRNA VaccinesLipidsSwine DiseasesMice, Inbred BALB CFemaleVaccines, SyntheticRNA, MessengerLiposomes

Stichwörter der Autor:innen

glycoprotein DmRNA vaccinepseudorabies virusvaccine

Substanzen

Antibodies, NeutralizingAntibodies, ViralLipid NanoparticlesViral Envelope ProteinsmRNA VaccinesPseudorabies VaccinesLipidsVaccines, SyntheticRNA, MessengerLiposomes

Autor:innen und Institutionen

  • State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
  • Hebei Key Laboratory of Analysis and Control of Zoonotic Pathogenic Microorganism, College of Life Sciences, Hebei Agricultural University, Baoding, China.
  • College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.
  • HBAU-Hemu Joint R&D Center for Animal mRNA Vaccine, Daqing, China.
  • Heilongjiang Provincial Research Center for Veterinary Biomedicine, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
  • Heilongjiang Provincial Key Laboratory of Veterinary Immunology, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.

ORCID-Profile: Hongliang Zhang, Fei Yu, Xue-Hui Cai, Yan-Dong Tang

Förderung

  • China National Key Research and Development Program during the 14-th Five-year Plan Period

Zitieren

APA

Sun, Y., Xu, S. J., Zhou, Y., Zhang, Y., Zhang, H., Le, T., Bai, Y. Z., Rao, C. H., Huo, S., Zhou, T., An, T. Q., Yin, X., Yu, F., Cai, X. H., & Tang, Y. D. (2025). A glycoprotein D-targeted lipid nanoparticle-encapsulated mRNA vaccine elicits strong protective immunity against pseudorabies virus. Journal of Virology, 99(11). https://doi.org/10.1128/jvi.01472-25

Vancouver

Sun Y, Xu SJ, Zhou Y, Zhang Y, Zhang H, Le T, et al. A glycoprotein D-targeted lipid nanoparticle-encapsulated mRNA vaccine elicits strong protective immunity against pseudorabies virus. Journal of Virology. 2025;99(11). doi:10.1128/jvi.01472-25

BibTeX
@article{Sun2025,
  author = {Sun, Yue and Xu, Shi-Jia and Zhou, Yongfei and Zhang, Yanhe and Zhang, Hongliang and Le, Ting and Bai, Yuan-Zhe and Rao, Cui-Hong and Huo, Shanshan and Zhou, Tianceng and An, Tong-Qing and Yin, Xin and Yu, Fei and Cai, Xue-Hui and Tang, Yan-Dong},
  title = {A glycoprotein D-targeted lipid nanoparticle-encapsulated mRNA vaccine elicits strong protective immunity against pseudorabies virus},
  journal = {Journal of Virology},
  year = {2025},
  volume = {99},
  number = {11},
  doi = {10.1128/jvi.01472-25}
}
Kostenlos starten →